The expanding role of the otolaryngologist in managing infants and children with hearing loss

Otolaryngologic Clinics of North America

Volumn 35, Issue 4, 2002, Pages 699-710

  Kim, Sam Y ^a   Bothwell, Nici E ^a   Backous, Douglas D ^b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUDIOLOGY; CHILD; DISEASE ASSOCIATION; HEARING LOSS; HUMAN; INFANT; LANGUAGE DEVELOPMENT; MEDICAL SPECIALIST; NEWBORN SCREENING; PARENT; PATIENT CARE; PEDIATRICIAN; REVIEW; SPEECH DEVELOPMENT; TEACHER; WELLBEING;

CHILD, PRESCHOOL; COUNSELING; HEARING LOSS, CONDUCTIVE; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; OTOLARYNGOLOGY; PATIENT CARE TEAM; PHYSICIAN'S ROLE; PROFESSIONAL-FAMILY RELATIONS;

EID: 0036703886     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00049-X     Document Type: Review

References (58)

1. Pickett PP, Ahlstrom K. Early identification and intervention of hearing-impaired infants. Otolaryngol Clin North Am 1999;32(6):1020-35.
2. Mauk GW, Behrens TR. Historical, political, and technological context associated with early identification of hearing loss. Seminars in Hearing 1993;14:1-17.
3. Northern JL, Hayes DH. Universal screening for infant hearing impairment: Necessary, beneficial and justifiable. Audiology Today 1994;6:10-3.
4. Parving A. Congenital hearing disability: Epidemiology and identification: A comparison between two healthy authority districts. Int J Pediatr Otorhinolaryngol 1993;27:29-46.
5. Watkins P, Baldwin M, McEnery G. Neonatal at risk screening and the identification of deafness. Arch Dis Child 1991;66:1130-5.
6. Yoshinaga-Itano C, Sedey AL, Coulter DK, et al. Language of early- and later-identified children with hearing loss. Pediatrics 1998;102(5):1161-71.
7. Grundfast KM, Bluestone CD. Sudden or fluctuating hearing loss and vertigo in children due to perilymphatic fistula. Ann Otol Rhinol Laryngol 1978;87(6, pt 1):761-71.
8. McGee T, Wolters C, Stein L, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg 1992; 106:75-80.
9. Pappas DG, Mundy MR. Sensorineural hearing loss: Infectious agents. Laryngoscope 1982;92:752-4.
10. Stagno S, Reynolds DW, Amos CS, et al. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics 1977;59:669-78.
11. Boppana SB, Pass RF, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93-9.
12. Fowler KB, McCallister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130:624-30.
13. Pass FR, Stango S, Myers GJ, et al. Outcome of symptomatic congenital cytomegalovirus infection: Results of long-term longitudinal follow-up. Pediatrics 1980;66:758-62.
14. Gratz ES, Pollack MA, Zimmerman RD. Congenital facial palsy and ipsilateral deafness: Association with maternal diabetes mellitus. Int J Pediatr Otorhinolaryngol 1981;3:335-41.
15. Sohmer H, Freeman S. The importance of thyroid hormone in auditory development in the fetus and neonate. Audiol Neurootol 1996;1(3):137-47.
16. Church MW, Abel EL. Fetal alcohol syndrome: Hearing, speech, language, and vestibular disorders. Obstet Gynecol Clin North Am 1998; 25(1): 85-97.
17. Brookhouser PE. Sensorineural hearing loss in children. Pediatr Clin North Am 1996;43(6):1195-216.
18. Connolly AM, Volpe JJ. Clinical features of bilirubin ecephalopathy. Clin Perinatol 1990;17(2):371-9.
19. Rhee CK, Park HM, Yang YJ. Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses. Laryngoscope 1999;109(12):2005-8.
20. Sheykholeslami K, Kaga K. Otoacoustic emissions and auditory brainstem responses after neonatal hyperbilirubinemia. Int J Pediatr Otorhinolaryngol 2000; 52(1):65-73.
21. Griffiths MV. The incidence of auditory and vestibular disorders following head injury in children. J Laryngol Otol 1979;93:253-65.
22. Podoshin L, Fradis M. Hearing loss after head injury. Arch Otolaryngol Head Neck Surg 1975;101:15-8.
23. Vartiainen E, Karjalainen S, Karja J. Auditory disorders following head injury in children. Acta Otolaryngol (Stockh) 1985;99:529-36.
24. Grundfast KM. Hearing loss. In: Bluestone CD, Stool SE, editors. Pediatric otolaryngoly. Ed. 2. Philadelphia: WB Saunders; 1990. p. 203.
25. Jaffe BF. History and physical examination for evaluating hearing loss in children. In: Jaffe BF, editor. Hearing Loss in Children: A Comprehensive Text. Baltimore: University Park Press; 1977. p. 152.
26. Eckstein JD, Filip DJ, Watts JC. Hereditary thrombocytopenia, deafness, and renal disease. Ann Intern Med 1975;82(5):639-45.
27. Yue WL. Otolaryngological problems associated with thrombocytopenia purpura in children. Int J Pediatr Otorhinolaryngol 1988;15(1):87-92.
28. Remington JS. The tragedy of toxoplasmosis. Pediatr Infect Dis J 1990;9:762-3.
29. Wilson CB, Remington JS, Stagno S, et al. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980;66(5):767-74.
30. Fricker-Hidalgo H, Pelloux H, Racinet C, et al. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo and in vitro cultures. Placenta 1998;19(7):545-9.
31. Morriss MC, Hyder DJ, Zimmerman RA. Neurodiagnostic techniques. Pediatr Rev 1997;18(6):192-204.
32. Hughes D, Rutherford I. Predictive value of serologic tests for syphilis in otology. Ann Otol Rhinol Laryngol 1986;95(3, pt 1):250-9.
33. Bordley JE, Brookhouser PE, Hardy WG. Prenatal rubella. Acta Otolaryngol 1968;66:1-9.
34. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13(2):315-29.
35. McCollister FP, Simpson LC, Dahle AJ, et al. Hearing loss and congenital symptomatic cytomegalovirus infection: A case report of multidisciplinary longitudinal assessment and intervention. J Am Acad Audiol 1996;7(2):57-62.
36. Shusterman D, Handler SD, Marsh RR, et al. Usefulness of computed tomographic scan in the evaluation of sensorineural hearing loss in children. Arch Otolaryngol Head Neck Surg 1992; 118(5):501-3.
37. Zalzal GH, Shott SR, Towbin R, et al. Value of CT scan in the diagnosis of temporal bone diseases in children. Laryngoscope 1986;96(1):27-32.
38. Lowe LH, Vezina LG. Sensorineural hearing loss in children. Radiographics 1997;17(5):1079-93.
39. Boppana SB, Fowler KB, Vaid Y, et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997;99(3):409-14.
40. Westerhof JP, Rademaker J, Weber BP, et al. Congenital malformations of the inner ear and the vestibulocochlear nerve in children with sensorineural hearing loss: evaluation with CT and MRI. J Comput Assist Tomogr 2001;25(5):719-26.
41. Frasier GR. Sex-linked congenital deafness and excess of males in profound childhood deafness. Ann Hum Genet 1965;29:171-96.
42. Epstein FH. Genetic causes of hearing loss. N Engl J Med 2000;342(15):1101-9.
43. Bruzzone R, White TW, Goodenough DA. The cellular internet: on-line with connexins. Bioessays 1996;18:709-18.
44. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84:381-8.
45. Kelly PM, Harris DJ, Comer BC, et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998;62:792-9.
46. Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med 1998;339:1500-5.
47. Callison DM. Audiologic evaluation of hearing-impaired infants and children. Otolaryngol Clin North Am 1999;32(6):1009-18.
48. Brigss RJS, Luxford WM. Correction of conductive hearing loss in children. Otolaryngol Clin North Am 1994;27(3):607-20.
49. Bergstrom L. Assessment and consequence of malformation of the middle ear. Birth Defects 1980;16(4):217-41.
50. Funasaka S, Abe H, Tozuka G, et al. Anomalies of ossicles without malformations of the external ear. Otologia Fukuoka 1971;17:250-7.
51. Crowe SJ, Polvogt LM. Embryonic tissue in the middle ear and mastoid. Arch Otolaryngol Head Neck Surg 1930;12:151-61.
52. Takahara T, Sando I, Hashida Y, et al. Mesenchyme remaining in human temporal bones. Otolaryngol Head Neck Surg 1986;95:349-57.
53. Buch NH, Jorgensen MB. Leukocytic infiltration in middle ear of newborn infants: A pathological study. Arch Otolaryngol Head Neck Surg 1964;80:141-8.
54. Aschoff L. Die otitis media neonatorum. Ein beitrag zur entwicklungsgeschichte der paukenhohle. Zohrenheilk 1897;31:295-346.
55. deSa DJ. Polypoidal organization of aspirated amniotic squamous debris (amnionnodusm) in middle-ear cavity of newborn infants. Arch Dis Child 1977;52:148-51.
56. Martin FN, Gravel KL. Pediatric audiology practices in the United States. Hearing Journal 1989;42:33.
57. Winter M, Eisenberg L. Early identification and intervention of hearing-impaired infants. Otolaryngol Clin North Am 1999;32(6):1051-65.
58. Heffron MC. Clarifying concepts of infant mental health-promotion, relationship-based preventive intervention, and treatment. Inf Young Children 2000;12(4):14-21.